13F-HR: Walgreens Boots Alliance Discloses Major Equity Holdings in Latest 13F Filing

Walgreens Boots Alliance's latest 13F filing reveals substantial holdings in BrightSpring Health Services and Cencora, Inc.

Summary

• Walgreens Boots Alliance, Inc. filed its Form 13F holdings report for the quarter ended December 31, 2024.
• The filing discloses two holdings: BrightSpring Health Services Inc. and Cencora, Inc.
• The total value of the reported holdings amounts to $4,884,883,532.
• The filing includes information on other managers: Walgreen Co., WBA Investments, Inc., and Walgreens Boots Alliance Holdings LLC.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It provides factual information about the company's holdings.

Positives

• The filing provides transparency into Walgreens Boots Alliance's investment portfolio.
• The large holdings in BrightSpring Health Services and Cencora indicate strategic investments in the healthcare sector.

Industry Context

This filing provides insight into Walgreens Boots Alliance's investment strategy within the healthcare and pharmaceutical distribution industries, as reflected by its significant holdings in BrightSpring Health Services and Cencora.

Comparison to Industry Standards

• Without additional context, it's difficult to compare these holdings to industry standards.
• However, large institutional investors like Walgreens Boots Alliance often hold significant positions in publicly traded companies within their respective sectors.
• Comparing the portfolio allocation and performance against peers such as CVS Health or other major pharmaceutical distributors would provide a more comprehensive assessment.

Stakeholder Impact

• Shareholders can use this information to understand Walgreens Boots Alliance's investment strategy.
• The holdings in BrightSpring Health Services and Cencora may impact the performance of Walgreens Boots Alliance's overall portfolio.

Key Dates